OSE Immunotherapeutics SA (ORPOF) Discussion of Tedopi Immunotherapy Pipeline and Clinical Progress Across Oncology Indications - Slideshow

2026-06-12. The following slide deck was published by OSE Immunotherapeutics SA in conjunction with this event.